ESI - Element Solutions Inc
NYSE
->
Basic Materials
->
Specialty Chemicals
Fort Lauderdale,
United States
Type: Equity
ESI price evolution
ESI
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $286.3 | $289.3 | $329.6 | $282.4 |
| Short term investments | ||||
| Net receivables | $459 | $461.8 | $449.5 | $452.2 |
| Inventory | $319.1 | $298.9 | $322.8 | $332.8 |
| Total current assets | $1235.8 | $1197.5 | $1299.5 | $1256.5 |
| Long term investments | ||||
| Property, plant & equipment | $295.5 | $296.9 | $279.2 | $282.5 |
| Goodwill & intangible assets | $3142.3 | $3216 | $3171.1 | $3328.1 |
| Total noncurrent assets | $3676.4 | $3776.6 | $3669.3 | $3804.5 |
| Total investments | ||||
| Total assets | $4912.2 | $4974.1 | $4968.8 | $5061 |
| Current liabilities | ||||
| Accounts payable | $132.9 | $140.6 | $143.8 | $144.1 |
| Deferred revenue | ||||
| Short long term debt | $11.5 | $11.5 | $11.5 | $11.5 |
| Total current liabilities | $340.9 | $369.4 | $376.7 | $378.1 |
| Long term debt | $1918.9 | $1921 | $2027.8 | $2029.4 |
| Total noncurrent liabilities | $2232 | $2260.4 | $2345.9 | $2363.2 |
| Total debt | $1930.4 | $1932.5 | $2039.3 | $2040.9 |
| Total liabilities | $2572.9 | $2629.8 | $2722.6 | $2741.3 |
| Shareholders' equity | ||||
| Retained earnings | -$1146.8 | -$1183.3 | -$1241.2 | -$1189.9 |
| Other shareholder equity | -$384.2 | -$345.9 | -$387.1 | -$361.9 |
| Total shareholder equity | $2323.7 | $2328.5 | $2230.2 | $2303.5 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $289.3 | $265.6 | $330.1 | $291.9 |
| Short term investments | ||||
| Net receivables | $461.8 | $455.8 | $492.2 | $403.4 |
| Inventory | $298.9 | $290.7 | $274.4 | $203.1 |
| Total current assets | $1197.5 | $1188.7 | $1214.5 | $989.9 |
| Long term investments | ||||
| Property, plant & equipment | $296.9 | $362.3 | $278.1 | $240.4 |
| Goodwill & intangible assets | $3216 | $3218.3 | $3483 | $3108.6 |
| Total noncurrent assets | $3776.6 | $3715 | $3923.9 | $3493.5 |
| Total investments | ||||
| Total assets | $4974.1 | $4903.7 | $5138.4 | $4483.4 |
| Current liabilities | ||||
| Accounts payable | $140.6 | $132.2 | $138.4 | $95.6 |
| Deferred revenue | ||||
| Short long term debt | $11.5 | $11.5 | $12.7 | $7.4 |
| Total current liabilities | $369.4 | $344.4 | $415.2 | $314.3 |
| Long term debt | $1921 | $1883.8 | $1894.2 | $1508.1 |
| Total noncurrent liabilities | $2260.4 | $2210.2 | $2222.4 | $1851 |
| Total debt | $1932.5 | $1895.3 | $1906.9 | $1515.5 |
| Total liabilities | $2629.8 | $2571.2 | $2637.6 | $2165.3 |
| Shareholders' equity | ||||
| Retained earnings | -$1183.3 | -$1223.8 | -$1331.9 | -$1473.2 |
| Other shareholder equity | -$345.9 | -$299.2 | -$197.4 | -$194.8 |
| Total shareholder equity | $2328.5 | $2332.5 | $2480.7 | $2319.8 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $575 | $573.4 | $599.3 | $586.1 |
| Cost of revenue | $330 | $353.1 | $357.4 | $357.6 |
| Gross Profit | $245 | $220.3 | $241.9 | $228.5 |
| Operating activities | ||||
| Research & development | $18.1 | $13.8 | $12.9 | $28.9 |
| Selling, general & administrative | $149.1 | $151 | $149.9 | $147 |
| Total operating expenses | $167.2 | $164.8 | $242.8 | $175.9 |
| Operating income | $77.8 | $55.5 | -$0.9 | $52.6 |
| Income from continuing operations | ||||
| EBIT | $83.4 | $49 | -$3.2 | $63.1 |
| Income tax expense | $13.5 | -$40.4 | $15.3 | $21.2 |
| Interest expense | $13.9 | $12.3 | $13.3 | $12 |
| Net income | ||||
| Net income | $56 | $77.1 | -$31.8 | $29.9 |
| Income (for common shares) | $56 | $77.1 | -$31.8 | $29.9 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2333.2 | $2549.4 | $2399.8 | $1853.7 |
| Cost of revenue | $1414.7 | $1596.7 | $1439 | $1067.7 |
| Gross Profit | $918.5 | $952.7 | $960.8 | $786 |
| Operating activities | ||||
| Research & development | $68.1 | $48.8 | $49.7 | $48.6 |
| Selling, general & administrative | $596.8 | $578.6 | $611.2 | $504.7 |
| Total operating expenses | $744.9 | $627.4 | $660.9 | $553.3 |
| Operating income | $173.6 | $325.3 | $299.9 | $232.7 |
| Income from continuing operations | ||||
| EBIT | $180.4 | $324.2 | $305.8 | $143.4 |
| Income tax expense | $13 | $85.8 | $48.3 | $4.3 |
| Interest expense | $49.3 | $51.2 | $54.2 | $63.4 |
| Net income | ||||
| Net income | $118.1 | $187.2 | $203.3 | $75.7 |
| Income (for common shares) | $118.1 | $187.2 | $203.3 | $75.7 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | $56 | $77.1 | -$31.8 | $29.9 |
| Operating activities | ||||
| Depreciation | $40.3 | $42 | $44.5 | $41.1 |
| Business acquisitions & disposals | -$3.9 | -$26.2 | -$0.3 | -$188.3 |
| Stock-based compensation | $4.1 | -$1.2 | $2.9 | $3.3 |
| Total cash flows from operations | $58.2 | $111.8 | $87.4 | $80.9 |
| Investing activities | ||||
| Capital expenditures | -$19 | -$16.4 | -$12.5 | -$13.8 |
| Investments | ||||
| Total cash flows from investing | -$22.9 | -$24 | -$12.5 | -$202.1 |
| Financing activities | ||||
| Dividends paid | -$20 | -$19.3 | -$19.4 | -$19.3 |
| Sale and purchase of stock | ||||
| Net borrowings | -$2.9 | -$108.4 | -$2.8 | $147.1 |
| Total cash flows from financing | -$32.7 | -$133.3 | -$22.7 | $126.8 |
| Effect of exchange rate | -$5.6 | $5.9 | -$5 | -$5.1 |
| Change in cash and equivalents | -$3 | -$40.3 | $47.2 | $3.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $118.1 | $187.2 | $203.3 | $75.7 |
| Operating activities | ||||
| Depreciation | $166.7 | $161.3 | $163.9 | $161.4 |
| Business acquisitions & disposals | -$214.8 | -$22.6 | -$536.5 | -$9 |
| Stock-based compensation | $9.4 | $17.7 | $40.1 | $6 |
| Total cash flows from operations | $333.6 | $295.9 | $326 | $261.3 |
| Investing activities | ||||
| Capital expenditures | -$51.3 | -$43 | -$46.3 | -$27.1 |
| Investments | ||||
| Total cash flows from investing | -$250.2 | -$75.2 | -$568.9 | -$39.9 |
| Financing activities | ||||
| Dividends paid | -$77.4 | -$78.4 | -$61.9 | -$12.4 |
| Sale and purchase of stock | -$151 | -$19.6 | -$55.7 | |
| Net borrowings | $33 | -$16.4 | $388 | -$7.9 |
| Total cash flows from financing | -$58.7 | -$275.6 | $290 | -$123.6 |
| Effect of exchange rate | -$3.2 | -$11.4 | -$5.4 | $4 |
| Change in cash and equivalents | $23.7 | -$64.5 | $38.2 | $101.8 |
News
Fundamentals
| Market cap | $5.79B |
|---|---|
| Enterprise value | $7.44B |
| Shares outstanding | 242.00M |
| Revenue | $2.33B |
|---|---|
| EBITDA | $360.20M |
| EBIT | $192.30M |
| Net Income | $131.20M |
| Revenue Q/Q | 0.10% |
| Revenue Y/Y | -4.49% |
| P/E ratio | 44.14 |
|---|---|
| EV/Sales | 3.19 |
| EV/EBITDA | 20.64 |
| EV/EBIT | 38.66 |
| P/S ratio | 2.48 |
| P/B ratio | 2.14 |
| Book/Share | 11.19 |
| Cash/Share | 1.18 |
| EPS | $0.54 |
|---|---|
| ROA | 2.64% |
| ROE | 5.71% |
| Debt/Equity | 1.13 |
|---|---|
| Net debt/EBITDA | 6.35 |
| Current ratio | 3.63 |
| Quick ratio | 2.69 |